Kirin Cashes Out of Amgen Drug Joint Venture for $780M Post author:Sam Post published:October 30, 2017 Post category:BioPharma Amgen and Kirin have decided to dissolve their joint venture, Kirin-Amgen. Source: BioSpace You Might Also Like GlaxoSmithKline Poaches Another Top Exec—This Time From Pfizer July 12, 2017 Biogen Exec Leaves to Put Together and Helm New Biotech Startup May 10, 2017 PhaseRx Reports First Quarter 2017 Financial Results and Provides Corporate Update May 11, 2017
